These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6948980)

  • 1. Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester.
    Todd RF; Griffin JD; Ritz J; Nadler LM; Abrams T; Schlossman SF
    Leuk Res; 1981; 5(6):491-5. PubMed ID: 6948980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of differentiation of human myelomonocytic cell lines by chemical inducers: analysis of surface antigens with monoclonal antibodies].
    Yamada K; Okabe N; Saito H; Suzuki R
    Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):703-8. PubMed ID: 6591672
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyamine requirements for induction of HL-60 promyelocyte differentiation by leukocyte-conditioned medium and phorbol ester.
    Kufe DW; Griffin J; Mitchell T; Shafman T
    Cancer Res; 1984 Oct; 44(10):4281-4. PubMed ID: 6432308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
    Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
    J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase activity increases in HL60 cells induced to differentiate with retinoic acid and TPA but not with DMSO.
    Maddox AM; Haddox MK
    Exp Cell Biol; 1985; 53(5):294-300. PubMed ID: 2864293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action.
    Rovera G; Ferrero D; Pagliardi GL; Vartikar J; Pessano S; Bottero L; Abraham S; Lebman D
    Ann N Y Acad Sci; 1982 Dec; 397():211-20. PubMed ID: 6961843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of human bone marrow in vitro.
    Svet-Moldavsky I; Gulati SC; Clarkson B
    Cell Biol Int Rep; 1985 Sep; 9(9):833-40. PubMed ID: 3876165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of complement receptors of a human monocyte cell line, U-937, during incubation with phorbol myristate acetate: expression of an iC3b-specific receptor (CR3).
    Gilbert D; Peulve P; Daveau M; Ripoche J; Fontaine M
    Eur J Immunol; 1985 Oct; 15(10):986-91. PubMed ID: 2932340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line.
    Fontana JA; Colbert DA; Deisseroth AB
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3863-6. PubMed ID: 6943586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promoter.
    Namikawa R; Ogata S; Ueda R; Tsuge I; Nishida K; Minami S; Koike K; Suchi T; Ota K; Iijima S; Takahashi T
    Leuk Res; 1983; 7(3):375-87. PubMed ID: 6604202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters.
    Rovera G; O'Brien TG; Diamond L
    Science; 1979 May; 204(4395):868-70. PubMed ID: 286421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplication of human fetal myelomonocytic precursors in medium conditioned by acute myelocytic leukemia cells treated by 12-O-tetradecanoyl phorbol 13-acetate (TPA).
    Svet-Moldavsky IA; Den T; Bowers CH; Wroblesky H
    Biomed Pharmacother; 1985; 39(9-10):472-7. PubMed ID: 3869046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell killing by phorbol ester--differentiated human leukemia cells.
    Weinberg JB
    Science; 1981 Aug; 213(4508):655-7. PubMed ID: 7196085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor.
    Imaizumi M; Uozumi J; Breitman TR
    Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells.
    Hickstein DD; Smith A; Fisher W; Beatty PG; Schwartz BR; Harlan JM; Root RK; Locksley RM
    J Immunol; 1987 Jan; 138(2):513-9. PubMed ID: 2947951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ and phorbol ester synergistically induce HL-60 differentiation.
    Tyers M; Harley CB
    FEBS Lett; 1986 Sep; 206(1):99-105. PubMed ID: 3093277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of an activation antigen, Mo3e, associated with the cellular response to migration inhibitory factor by HL-60 promyelocytes undergoing monocyte-macrophage differentiation.
    Todd RF; Bury MJ; Liu DY
    J Leukoc Biol; 1987 Jun; 41(6):492-9. PubMed ID: 3036984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally deficient differentiation of HL-60 promyelocytic leukemia cells induced by phorbol myristate acetate.
    Newburger PE; Baker RD; Hansen SL; Duncan RA; Greenberger JS
    Cancer Res; 1981 May; 41(5):1861-5. PubMed ID: 6260353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
    Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA
    Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.